Generation of mesenchymal stem cells by blood cell reprogramming

Research output: Contribution to journalReview articlepeer-review

Abstract

Mesenchymal stem cells (MSCs) have been successfully used to treat multiple diseases in animal studies and clinical trials. Currently, the commonly used MSCs are derived from bone marrow and adipose tissue. Alternative approaches include differentiation of induced pluripotent stem cells (iPSCs) into MSCs, or direct reprogramming of blood cells into MSCs. This review summarizes recent progresses concerning how to generate MSCs by blood cell reprogramming and how studies in cellular reprogramming may help identify new factors to expand or even rejuvenate adult MSCs.

Original languageEnglish
Pages (from-to)114-121
Number of pages8
JournalCurrent Stem Cell Research and Therapy
Volume11
Issue number2
DOIs
StatePublished - Jan 1 2016

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)

Keywords

  • Blood
  • Hematopoietic cells
  • Induced pluripotent stem cells
  • Mesenchymal stem cells
  • Reprogramming

Cite this